Do patients lie? An open interview vs. a blind questionnaire on sexuality.

Introduction: Postmenopausal women are often hesitant to discuss their sexual attitudes and experiences surrounding sexuality with her doctors. Sociocultural, ethnic, and medical background may affect the attitude towards menopause and the expectations regarding sexuality in these women.

Aim: To describe communication about sex between patients and doctors and its relation to extrinsic limiting factors.

Impact of anthropometric parameters on quality of life during menopause.

Objective: To investigate whether body mass index (BMI), abdominal obesity, and fat distribution in postmenopausal women influence quality of life.

Design: Cross-sectional survey.

Setting: Outpatient clinics in the hospital setting and private practices.

Understanding how personality factors may influence quality of life: development and validation of the Cervantes Personality Scale.

Objective: To develop and validate a simple personality scale to be used as a complementary tool for menopause-specific quality-of-life instruments.

Design: A population-based random sample of 2,274 Spanish women stratified by age groups and education level was used in the validation phase. The initial 94-item questionnaire was reduced to 20 items by examining the frequency and variability with which women were responding to each of the items.

[Health-related quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale].

Background And Objective: There are numerous health-related quality of life questionnaires but only a few are specific for the menopause. The objective of this study was to develop and validate a specific scale, the Cervantes Scale, for menopause in Spanish women.

Subjects And Method: This cross-sectional study included a pilot phase, construction of the questionnaire, validation, and test-retest reliability.

Non-linear pharmacokinetic modelling of intravenous elgodipine.

Unlabelled: OBJECTIVE, SUBJECTS AND METHODS: The 1,4-dihydropyridine elgodipine was given as continuous infusion at various rates (5, 10, 15, 20, 40 microg/kg/h for 48, 48, 48, 24, or 6 h, respectively) to five groups of 6-12 healthy male subjects (total 42). Elgodipine plasma concentrations were measured with HPLC in 20-24 samples from each subject. Concentrations increased overproportionally with dose.